Prism Medico and Pharmacy Ltd. (PRISMMEDI) Share Price Surges 9.4% Today

Prism Medico and Pharmacy Ltd. Share Price surges 9.4% today, reaching Rs 28.75 with a market cap of Rs 35.64 Cr.

Prism Medico and Pharmacy Ltd. Share Price has seen a significant rise today, with the stock closing at Rs 28.75, marking a 9.4% increase from its previous close of Rs 26.28. This price movement has brought the company's market capitalisation to Rs 35.64 crore, categorising it as a micro-cap stock. The substantial gain has caught the attention of investors, as it surpasses the qualifying threshold of 8.1% set for its market-cap category.

The stock opened at Rs 26.5 and reached a high of Rs 28.9 during the trading session, with a low of Rs 25. The total trading volume on the BSE was 16,432 shares, reflecting a turnover of Rs 0.05 crore. This increase in share price positions Prism Medico and Pharmacy Ltd. as a top gainer in the market today, drawing interest from market participants and analysts alike.

Prism Medico and Pharmacy Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 28.75
Previous Close	Rs 26.28
Today's Change	+Rs 2.47 (+9.4%)
Day Open	Rs 26.5
Day High	Rs 28.9
Day Low	Rs 25
Current Volume (BSE)	16,432
BSE Traded Volume	16,432
Combined NSE + BSE Volume	16,432
Turnover	Rs 0.05 crore
Market Capitalisation	Rs 35.64 crore
Market Cap Category	Micro Cap
Qualifying Threshold Cleared	8.1%

Today's trading session for Prism Medico and Pharmacy Ltd. was marked by a robust price action, with the stock closing at Rs 28.75, a 9.4% increase from the previous close of Rs 26.28. The stock opened at Rs 26.5, reached a high of Rs 28.9, and touched a low of Rs 25. The day's turnover amounted to Rs 0.05 crore, with a total volume of 16,432 shares traded on the BSE.

As a micro-cap stock, Prism Medico and Pharmacy Ltd. cleared the qualifying threshold of 8.1% for its market-cap category, making today's rally noteworthy. The trading volume was consistent with the average, indicating steady investor interest. This price rise places the company among the top gainers in the market, highlighting its potential for further analysis.

Prism Medico and Pharmacy Ltd. Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 35.64 crore
P/E Ratio	111.39x
P/B Ratio	1.56x
ROE	-1%
ROCE	-1.35%
EPS	Rs 0.24
Book Value Per Share	Rs 16.89
Dividend Yield	0%

Prism Medico and Pharmacy Ltd. was valued at a P/E ratio of 111.39x, a P/B ratio of 1.56x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -1% and ROCE of -1.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 0.24, book value per share of Rs 16.89, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Prism Medico and Pharmacy Ltd. has a market capitalisation of Rs 35.64 crore and an enterprise value that reflects its micro-cap status. The company's price-to-earnings (P/E) ratio is 111.39, significantly higher than the industry median of 14.15, indicating a potentially expensive valuation relative to its peers.

The price-to-book (P/B) ratio stands at 1.56, which is slightly above the industry median of 1.31. The company's return on equity (ROE) is -1%, and the return on capital employed (ROCE) is -1.35%, both of which are below industry averages, suggesting challenges in profitability and capital efficiency.

The earnings per share (EPS) is Rs 0.24, and the book value per share is Rs 16.89, providing insight into the company's earnings potential and asset backing. The dividend yield is currently 0%, indicating no dividend payout to shareholders. These fundamentals highlight areas where the company may need to improve to attract more investor interest.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Companies in Benchmark	455
Company P/E Ratio	111.39x
Benchmark Median P/E	14.15x
Benchmark Average P/E	68.52x
Benchmark P/E Range	0x to 2,173.6x
Companies with P/E Data	455
Company P/B Ratio	1.56x
Benchmark Median P/B	1.31x
Company ROE	-1%
Benchmark Median ROE	1.71%
Company ROCE	-1.35%
Benchmark Median ROCE	3.41%
Company Market Capitalisation	Rs 35.64 crore
Benchmark Median Market Cap	Rs 42.2 crore

Prism Medico and Pharmacy Ltd. (PRISMMEDI) is classified under sector: Trading and industry: Trading. The numerical benchmark uses 455 same industry companies from the supplied master-data set.

Prism Medico and Pharmacy Ltd. (PRISMMEDI) has a P/E ratio of 111.39x, which is above the benchmark median of 14.15x, a difference of +687.21%. The benchmark contains 455 companies with P/E data, ranging from 0x to 2,173.6x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Prism Medico and Pharmacy Ltd. (PRISMMEDI) has a ROE of -1%, which is below the benchmark median of 1.71%, a difference of -158.48%. Prism Medico and Pharmacy Ltd. (PRISMMEDI) has a ROCE of -1.35%, which is below the benchmark median of 3.41%, a difference of -139.59%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Prism Medico and Pharmacy Ltd. operates within the Trading sector, which includes 455 companies. The company's P/E ratio of 111.39 is significantly above the sector median of 14.15, suggesting a high valuation compared to its peers. The sector's P/B ratio median is 1.31, with Prism Medico slightly above at 1.56.

The sector's ROE median is 1.71%, and the ROCE median is 3.41%, both of which are higher than Prism Medico's figures of -1% and -1.35%, respectively. This indicates that the company is underperforming in terms of profitability and efficiency compared to its sector peers.

The Trading sector's market capitalisation median is Rs 42.2 crore, with Prism Medico's market cap at Rs 35.64 crore, placing it below the median. This context underscores the challenges and opportunities within the sector, highlighting the need for strategic improvements.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ashoka Metcast Ltd.	ASHOKAMET	35.34	3.27	0.29	0.66	2.98
Kabsons Industries Ltd.	KABSON	34.96	43.87	2.37	17.52	18.65
Nanavati Ventures Ltd.	NVENTURES	34.93	478.52	1.55	3.83	5.08
Cell Point (India) Ltd.	CELLPOINT-SM	37.46	594.68	0.5	6.08	15.75
Biogen Pharmachem Industries Ltd.	BIOGEN	33.7	39.18	0.3	-2.92	-2.91

Prism Medico and Pharmacy Ltd. (PRISMMEDI) has a P/E ratio of 111.39x compared with the displayed peer median of 43.87x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -1% compares with a peer median of 3.83% across the companies shown in the table. ROCE stood at -1.35% versus the displayed peer median of 5.08%, providing a capital-efficiency comparison. Prism Medico and Pharmacy Ltd. (PRISMMEDI) has a market capitalisation of Rs 35.64 crore. Among the 5 peers shown, 1 have a larger market capitalisation.

In comparison to its peers, Prism Medico and Pharmacy Ltd. shows a mixed performance. Ashoka Metcast Ltd. has a P/E ratio of 3.27, significantly lower than Prism Medico's 111.39, indicating a more attractive valuation. Kabsons Industries Ltd. has a P/E of 43.87, also lower than Prism Medico's, with a higher ROE of 17.52% and ROCE of 18.65%, suggesting better profitability and efficiency.

Nanavati Ventures Ltd. has a P/E of 478.52, much higher than Prism Medico's, but with a lower ROE of 3.83% and ROCE of 5.08%. Cell Point (India) Ltd. shows a P/E of 594.68, with a ROE of 6.08% and ROCE of 15.75%, indicating strong profitability. These comparisons highlight the competitive landscape and the areas where Prism Medico may need to focus on improving its financial metrics.

Why Investors Are Watching Prism Medico and Pharmacy Ltd.

Investors are closely monitoring Prism Medico and Pharmacy Ltd. due to its recent price surge and its position within the Trading sector. The following factors contribute to its current market interest:

• Significant price rise of 9.4% today, surpassing the micro-cap threshold.
• Neutral RSI indicating balanced momentum.
• High P/E ratio suggesting potential overvaluation.
• Negative ROE and ROCE highlighting profitability challenges.
• Position within a competitive Trading sector with room for improvement.

Investors should continue to monitor the company's financial performance, sector trends, and any strategic initiatives that may impact its future growth and valuation.

About Prism Medico and Pharmacy Ltd.

Prism Medico and Pharmacy Ltd. is engaged in the Trading industry, focusing on the distribution and sale of pharmaceutical and medical products. The company operates within a competitive sector, with a diverse range of products catering to various healthcare needs. Its business model revolves around leveraging its distribution network to reach a broad customer base, including hospitals, clinics, and retail pharmacies.

The company's revenue mix is primarily derived from the sale of pharmaceutical products, with a focus on expanding its market presence and product offerings. As a micro-cap company, Prism Medico faces challenges in scaling its operations and improving its financial metrics to compete effectively with larger industry players.

Track Prism Medico and Pharmacy Ltd. Share Price on Univest

Use Prism Medico and Pharmacy Ltd. (PRISMMEDI) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track the live share price of Prism Medico and Pharmacy Ltd. on Univest, along with detailed technical indicators, fundamental ratios, and shareholding patterns. Univest provides comprehensive market insights, including 52-week levels and sector performance, enabling investors to make informed decisions. Stay updated with the latest market trends and analysis on Univest.

Frequently Asked Questions

What is the current share price of Prism Medico and Pharmacy Ltd.?

Ans. The current share price of Prism Medico and Pharmacy Ltd. is Rs 28.75, reflecting a 9.4% increase from the previous close of Rs 26.28. The stock moved 9.4% during the session.

How much did Prism Medico and Pharmacy Ltd. share price increase today?

Ans. Prism Medico and Pharmacy Ltd. share price increased by 9.4% today, closing at Rs 28.75. The stock moved 9.4% during the session. The intraday range extended from Rs 25 to Rs 28.9.

What is the market capitalisation of Prism Medico and Pharmacy Ltd.?

Ans. The market capitalisation of Prism Medico and Pharmacy Ltd. is Rs 35.64 crore, categorising it as a micro-cap company. The company operates in the Trading sector. Its P/E ratio is 111.39x.

What is the P/E ratio of Prism Medico and Pharmacy Ltd.?

Ans. The P/E ratio of Prism Medico and Pharmacy Ltd. is 111.39, significantly higher than the industry median of 14.15. The company trades at a P/E ratio of 111.39x. Its P/B ratio is 1.56x.

What is the ROE of Prism Medico and Pharmacy Ltd.?

Ans. The return on equity (ROE) of Prism Medico and Pharmacy Ltd. is -1%, below the industry median of 1.71%. ROE stands at -1%. ROCE stands at -1.35%. The relevant peer median ROE is 1.71%.

What sector does Prism Medico and Pharmacy Ltd. operate in?

Ans. Prism Medico and Pharmacy Ltd. operates in the Trading sector, focusing on the distribution and sale of pharmaceutical products. The stock belongs to the Trading sector. Its industry classification is Trading.

Who are the peers of Prism Medico and Pharmacy Ltd.?

Ans. Peers of Prism Medico and Pharmacy Ltd. include Ashoka Metcast Ltd., Kabsons Industries Ltd., and Nanavati Ventures Ltd., among others. Comparable listed companies include Ashoka Metcast Ltd., Kabsons Industries Ltd., Nanavati Ventures Ltd.